biomedicina slovenica

re="Cancer" : 401-500

  1. Biganzoli L; Bonnefoi H; Mauriac L; Čufer T; Kabanga-Ngalula E; Hebert D; Piccart M
    Cyclophosphamide (C) - Epirubicine (E) - Capecitabine (X) combination, CEX: a safe and active regimen in the treatment of locally advanced/inflammatory (LA/I) or large operable (LO) breast cancer (BC). An EORTC-IDBBC study
    2001 ►
  2. Žgajnar J; Hočevar M; Bešić N; Vrščaj M; Pajk B; Čufer T; Jakopin C; Krajc M
    Genetic counceling for hereditary breast and ovarian cancer. Our experience at the Institute of oncology in Ljubljana, Slovenija
    2002 ►
  3. Jagodic M; Vrhovec I; Borštnar S; Matos E; Čufer T
    Prognostic value of different proteolitic factors in primary breast cancer
    2002 ►
  4. Matos E; Vrhovec I; Borštnar S; Jagodic M; Čufer T
    Predictive value of PAI-1 and PAI-2 in breast cancer
    2002 ►
  5. Pajk B; Borštnar S; Vrhovec I; Čufer T
    PAI-1 is independant prognostic factor in the elderly breast cancer patients
    2002 ►
  6. International breast cancer study group J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial
    2002 ►
  7. Levičar Nataša; Kos Janko; Blejec Andrej; Golouh Rastko; Vrhovec Ivan; Frkovič-Grazio Snježana; Lah Tamara T
    Comparison of potential biological markers cathepsin B, cathepsin L, stefin A, and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients
    2002 ►
  8. Clayton Richard N; Pfeifer Marija; Atkinson A Brew; Belchetz Paul; Wass John AH; Kyrodimou Effie; Vanderpump Mark; Simpson David; Bicknell John; Farrell William E
    Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins
    2000 ►
  9. Čemažar Maja; Wilson John; Prise Vivien E; Hill Sally A; Tozer Gillian M
    Endothelin ETB receptor agonist IRL 1620 cause a decrease in blood flow in the rat P22 tumour model
    2000 ►
  10. Hočevar M; Glumac N; Novaković S; Snoj M
    The role of serum S-100 protein and thyrosinase RT-PCR in staging patients with malignant melanoma
    2001 ►
  11. Bonnefoi H; Biganzoli L; Čufer T; Mauriac L; Hamilton A; Schaefer P; Picart M
    An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer
    2001 ►
  12. Look Maxime P; van Putten Wim LJ; Duffy Michael J; Harbeck Nadia; Christensen Ib Jarle; Thomsen Christoph; Kates Ronald; Spyratos Frederique; Fernoe Marten; Čufer Tanja; Borštnar Simona
    Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients
    2002 ►
  13. Čemažar Maja; Serša Gregor; Wilson John; Tozer Gillian M; Hart Stephen L; Grosel Alenka; Dachs Gabi U
    Effective gene transfer to solid tumours using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector
    2002 ►
  14. Kranjc Simona; Čemažar Maja; Grošel Alenka; Serša Gregor
    Antivascular effect of electrochemotherapy with cisplatin
    2001 ►
  15. Tupper J; Greco O; Čemažar M; Tozer GM; Dachs GU
    DNA transfer to tumour cells in vitro and in vivo for gene directed enzyme prodrug therapy
    2001 ►
  16. Serša Gregor; Čemažar Maja
    A potential vascular targeted mechanism of electrochemotherapy
    2001 ►
  17. Čemažar Maja; Dachs Gabi U; Wilson Ian; Tozer Gillian M; Serša Gregor
    In vivo gene delivery to solid tumors by electroporation alone or combined with lipofectin-based techniques
    2001 ►
  18. Primic-Žakelj Maja
    Epidemiology of breast cancer in the XXI century
    2001 ►
  19. Tozer Gillian M; Prise Vivien E; Wilson John; Čemažar Maja; Shan Siqing; Dewhirst Mark W; Barber Paul R; Vojnović Borivoj; Chaplin David J
    Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability
    2001 ►
  20. Coebergh J-W; Pastore G; Gatta G; Corazziari I; Kamps W; Pompe-Kirn V
    Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978-1992: the EUROCARE study
    2001 ►
  21. Sant M; Capocaccia R; Coleman MP; Berrino F; Gatta G; Micheli A; Verdecchia A; Faivre J; Hakulinen T; Pompe-Kirn V
    Cancer survival increases in Europe, but international differences remain wide
    2001 ►
  22. Coralli Claudia; Čemažar Maja; Kanthou Chryso; Tozer Gillian M; Dachs Gabi U
    Limitations of the reporter green fluorescent protein under simulated tumor conditions
    2001 ►
  23. Gatta G; Luksch R; Coleman MP; Corazziari I; Pompe-Kirn V
    Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study
    2001 ►
  24. Levi F; La Vecchia C; Negri E; Lucchini F; Pompe-Kirn V
    Childhood cancer mortality in Europe, 1955-1995
    2001 ►
  25. Terracini B; Coebergh J-W; Gatta G; Magnani C; Stiller C; Verdecchia A; Zappone A; Pompe-Kirn V
    Childhood cancer survival in Europe: an overview
    2001 ►
  26. Ećimović P; Pompe-Kirn V
    Incidence of second primary cancers in patients with selected smoking-related primary cancers in Slovenia
    2001 ►
  27. Primic-Žakelj M; Skrlec F; Pompe-Kirn V
    To what extent do the national death certification rates from cervical cancer reflect the true mortality from this cancer?
    2001 ►
  28. Pompe-Kirn V; Japelj B; Primic-Žakelj M; Šircel M
    Which risk factors could have affected breast cancer incidence in Slovenia in the past, and what are the predictions for this decade?
    2001 ►
  29. Stiller CA; Craft AW; Corazziari I; Pompe-Kirn V
    Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study
    2001 ►
  30. Storm HH; Plesko I; Pompe-Kirn V
    Survival of children with thyroid cancer in Europe 1978-1989
    2001 ►
  31. Moeller TR; Garwicz S; Corazziari I; Magnani C; Pompe-Kirn V
    Survival of children with liver tumours in Europe 1978-1989
    2001 ►
  32. Kramarova E; Mann JR; Magnani C; Corraziari I; Berrino F; Pompe-Kirn V
    Survival of children with malignant germ cell, trophoblastic and other gonadal tumours in Europe
    2001 ►
  33. Stiller CA; Stevens MCG; Magnani C; Corazziari I; Pompe-Kirn V
    Survival of children with soft-tissu sarcoma in Europe since 1978: results from the EUROCARE study
    2001 ►
  34. Conti EMS; Cercato MC; Gatta G; Ramazzotti V; Roscioni S; Pompe-Kirn V
    Childhood melanoma in Europe since 1978: a population-based survival study
    2001 ►
  35. Magnani C; Gatta G; Corazziari I; Kramarova E; Pastore G; Viscomi S; Stiller C; Pompe-Kirn V
    Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis
    2001 ►
  36. Čemažar M; Miklavčič D; Mir LM; Belehradek J-Jr; Bonnay M; Fourcault D; Serša G
    Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model
    2001 ►
  37. Čizmarevič Bogdan; Lanišnik Boštjan; Didanovič Vojko; Kramberger Kristina
    Surgical therapy for oral cavity and oropharyngeal squamous cell carcinoma: our experience
    2001 ►
  38. Garte Seymour; Gaspari Laura; Alexandrie Anna-Karin; Ambrosone Christine; Autrup Herman; Autrup Judith L; Baranova Helena; Bathum Lise; Breskvar Katja; Dolžan Vita
    Metabolic gene polymorphism frequencies in control populations
    2001 ►
  39. Triller N; Debeljak A
    Treatment of endobronchial tumours with electrocautery
    2001 ►
  40. Pastore G; Magnani C; Verdecchia A; Pession A; Viscomi S; Coebergh JW; Oberaigner W; Storm H; Aareleid T; Pompe-Kirn V
    Survival of childhood lymphomas in Europe, 1978-1992: a report from the EUROCARE study
    2001 ►
  41. Magnani C; Aareleid T; Viscomi S; Pastore G; Berrino F; Oberaigner W; Storm H; Hakulinen T; Mace-Lesec'h J; Pompe-Kirn V
    Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study
    2001 ►
  42. Sant M; Capocaccia R; Badioni V; Oberaigner W; Storm H; Aareleid T; Hakulinen T; Mace-Lesec'h J; Arveux P; Pompe-Kirn V
    Survival for retinoblastoma in Europe
    2001 ►
  43. Spix C; Aareleid T; Stiller C; Magnani C; Kaatsch P; Michaelis J; Oberaigner W; Storm H; Aareleid T; Pompe-Kirn V
    Survival of children with neuroblastoma. time trends and regional differences in Europe, 1978-1992
    2001 ►
  44. Berrino F; Gatta G; Sant M; Capocaccia R; Oberaigner W; Storm H; Aareleid T; Hakulinen T; Hedelin G; Pompe-Kirn V
    The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses
    2001 ►
  45. Pleško I; Kramarova E; Stiller CA; Coebergh J-W; Santaquilani M
    Survival of children with Wilms' tumour in Europe
    2001 ►
  46. Sok Miha; Šentjurc Marjeta; Schara Milan
    Membrane fluidity characteristics of human lung cancer
    1999 ►
  47. Brauch H; Weirich G; Brieger J; Glavač D; Rodl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Mašera A
    VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation
    2000 ►
  48. Debeljak A; Kecelj P; Kern I; Eržen J; Kovač V; Rott T
    Medical thoracoscopy in pleural malignant mesothelioma
    2001 ►
  49. Kovač V; Debevec M; Plaper-Vernik M; Debeljak A; Eržen J; Remškar Z; Kern I
    Malignant pleural mesothelioma (MPM) in Slovenia 1980-1997
    2001 ►
  50. Debeljak A; Kecelj P; Kern I
    Medical thoracoscopy in diffuse malignant pleural mesothelioma
    2001 ►
  51. Kos J; Sekirnik A; Kopitar G; Cimerman N; Kayser K; Stremmer A; Fiehn W; Werle B
    Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis
    2001 ►
  52. Potočnik U; Glavač D; Golouh R; Ravnik-Glavač M
    Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening
    2001 ►
  53. Filipič Metka; Fatur Tanja; Lah Tamara T
    The use of comet assay and methoxyamine to study the contribution of BER to N-methyl-N-nitrosourea (MNU) induced DNA single strand breaks (ssb)
    2000 ►
  54. Ećimović Patricija; Pompe-Kirn Vera
    Incidence of second primary cancers in patients with laryngeal cancer in Slovenia
    2000 ►
  55. Pompe-Kirn Vera; Japelj Barbara
    Trends in lung cancer and smoking habits in the female population of Slovenia
    2000 ►
  56. Tucker O; Hočevar M; Teng L; Gonzales D; Specht M; Fahey T
    COX-2 expression in thyroid cancer
    2000 ►
  57. Tucker ON; Teng LS; Hočevar M; Dannenberg AJ; Fahey TJ
    Bile acids induce cycloxygenase-2 in human pancreatic cancer cell lines
    1999 ►
  58. Dachs Gabi U; Čemažar Maja; Wilson Ian; Heller Richard; Heller Lorre C; Jaroszeski Mark J; Serša Gregor; Tozer Gillian M
    A comparison of gene delivery methods using electroporation and lipofectin-based techniques in vitro and in vivo
    2000 ►
  59. Bešić N; Rener M; Frković-Grazio S; Lindtner J; Žgajnar J; Gažić B
    Breast biopsy with needle localization: factors influencing complete excision of nonpalpable carcinoma
    2000 ►
  60. Awada A; Nooij M; Biganzoli L; Čufer T; Beek L; Batter V; Piccart MJ
    A phase I study of continuous infusion 5-fluorouracil (F-intu) in combination with gemcitabine (GEM) in patients (pts) with anthracycline- (A) refractory or A- and taxane- (T) pretreated metastatic breast cancer (MBC)
    2000 ►
  61. Uršič-Vrščaj M
    HRT in women with a history of breast cancer
    2000 ►
  62. Majdič E; Paulin-Košir S
    Locoregional control in breast cancer patients treated with mastectomy - is postoperative radiotherapy necessary?
    2000 ►
  63. Biganzoli L; Čufer T; Fargeot P; Rapoport B; Nooij M; Duchateau L; van Hoorebeeck I; Yague C; Epelbaum R; Piccart M
    Doxorubicin (A)/taxol (T): a safe regimen in terms of cardiac toxicity in the contex of an EORTC multicenter trial
    2000 ►
  64. Serša Gregor; Kranjc Simona; Čemažar Maja
    Improvement of combined modality therapy with cisplatin and radiations using electroporation of tumors
    2000 ►
  65. Miklavčič Damijan; Mir Lluis M
    Engineering perspective of in vitro electroporation
    2000 ►
  66. Novaković Srdjan
    Tumor vaccines against malignant melanoma
    2000 ►
  67. Budihna M; Šoba E; Šmid L; Zakotnik B; Lešničar H
    The treatment of advanced, inoperable squamous cell carcinoma of the oropharynx with radiotherapy and concomitant mitomycin C and bleomycin and some prognostic factors
    2000 ►
  68. Lešničar H
    Effect of thermoradiotherapy: a consequence of direct or indirect radiosensitization
    2000 ►
  69. Casar B; Miloševič Z; Sekereš B
    Polystyrene phantom for simulation of stereotactic radiosurgery using radichromic films
    2000 ►
  70. Jeraj Robert
    Importance of accurate dose calculation in inverse treatment planning
    2000 ►
  71. Robar Vlado
    BEAM: radiation therapy modeling tool
    2000 ►
  72. Ebert Martin; Boeing Nina; Georghegan Sean
    Dose-area analysis for endovascular brachytherapy
    2000 ►
  73. Keall Paul
    Potential therapeutic gains with gated radiotherapy
    2000 ►
  74. Vegelj-Pirc M; Škufca AC; Zalokar-Divjak Z; Purić F
    Psychological consequences of breast cancer on family life
    2000 ►
  75. Uršič-Vrščaj M; Bebar S
    Hormone replacement therapy in women with a history of breast cancer - a case control study
    2000 ►
  76. Jagodic M; Zakotnik B; Golouh R; Červek J; Čufer T
    Response to oral etoposide in advanced breast cancer: correlation with expression of c-erbB-2 protein
    2000 ►
  77. Serša Gregor; Kržič Mateja; Šentjurc Marjeta; Ivanuša Teodora; Beravs Katarina; Čemažar Maja; Auersperg Marija; Swartz Harold M
    Reduced tumor oxygenation by treatment with vinblastine
    2001 ►
  78. Čemažar M; Parkins CS; Holder AL; Chaplin DJ; Tozer GM; Serša G
    Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy
    2001 ►
  79. Strojan Primož; Budihna Marjan; Šmid Lojze; Svetic Branka; Vrhovec Ivan; Kos Janko; Škrk Janez
    Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck
    2000 ►
  80. Pompe-Kirn Vera; Japelj Barbara; Primic-Žakelj Maja
    Future trends in breast, cervical, lung, mouth and pharyngeal cancer incidence in Slovenia
    2000 ►
  81. Repše S; Jelenc F; Omejc M; Juvan R
    Intraperitoneal chemotherapy with mitomycin-C bound to activated particles (MC-CH) in radically operated gastric cancer patients (T3/4, NX, M0, R0)
    2001 ►
  82. Repše A; Juvan R; Križman I; Repše S
    Predictive factors for regional lymph node involvement in early gastric cancer patients
    2001 ►
  83. Omejc M; Juvan R; Jelenc F; Repše S
    Correlation between new (1997) and old (1987) UICC TNM classification
    2001 ►
  84. Debeljak A
    Comment on Katsimbri et al.: endobronchial metastases secondary to solid tumours, lung cancer
    2001 ►
  85. Omejc Mirko; Juvan Robert; Jelenc Franc; Repše Stane
    Correlation between new (1997) and old (1987) UICC TNM classification of gastric cancer
    2001 ►
  86. Repše Aljaž; Juvan Robert; Križman Igor; Repše Stane
    Predictive factors for regional lymph node involvement in early gastric cancer patients
    2001 ►
  87. Repše Stane; Jelenc Franc; Omejc Mirko; Juvan Robert
    Intraperitoneal chemotherapy with mitomycin-C bound to activated carbon particles in radically operated gastric cancer patients (T3/4, Nx, M0, R0)
    2001 ►
  88. Werle Bernd; Kraft Clemens; Lah Tamara T; Kos Janko; Schanzenbaecher Ulrike; Kayser Klaus; Ebert Werner; Spiess Eberhard
    Cathepsin B in infiltrated lymph nosed is of prognostic significance for patients with nonsmall cell lung carcinoma
    2000 ►
  89. Kos Janko; Krašovec Marta; Cimerman Nina; Nielsen Hans Jorgen; Christense Ib Jarle; Bruenner Nils
    Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis
    2000 ►
  90. Sier Cornelis FM; Casetta Giovanni; Verheijen Jan H; Tizziani Alessandro; Agape Vittorio; Kos Janko; Blasi Francesco; Hanemaaijer Roeland
    Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers
    2000 ►
  91. Kos J; Cimerman N; Werle B; Lah T; Bruenner N
    Cysteine proteinases and their inhibitors in tumors and blood of cancer patients: relation with prognosis, diagnosis and immune response
    2000 ►
  92. Kos J; Krašovec M; Schweiger A; Cimerman N; Štabuc B; Nielsen HJ; Christensen IJ; Stephens RW; Brunner N
    Prognostic relevance of serum cathepsins B, H and L and their inhibitors in melanoma and colorectal cancer
    1998 ►
  93. Rakar S; Rainer S; Kovačič J
    Experience with serous papillary tumors of the ovary
    1983 ►
  94. Ravnihar B
    A report of an on-going joint comparative study of cancer incidence in neighbouring regions of Austria, Czechoslovakia, Hungary and Yugoslavia
    1982 ►
  95. Rudolf Z; Serša G; Krošl G
    Monocyte mutation index as a nonspecific tumor marker in cancer patients
    1985 ►
  96. Krošl G; Rudolf Z; Serša G
    Colony growth of phytohemagglutinin stimulated peripheral blood lymphocytes in patients with malignant melanoma
    1985 ►
  97. Rudolf Z; Serša G; Krošl G
    Monocyte maturation index as a non-specific tumour marker in cancer patients
    1985 ►
  98. Lindtner J; Novak J; Naglas M; Červek J; Vodnik A; Majdič E; Mavec P; Golouh R; Lamovec J; Šebek S
    Adjuvant therapy for postmenopausal women with operable breast cancer- Part II - Randomized trials comparing endocrine therapy with surgery alone
    1984 ►
  99. Serša G; Krošl G; Rudolf Z
    The influence of fibrosarcoma bearing rat serum on the adherence and phagocytic capacity of monoculear cells
    1985 ►
  100. Ravnihar B; Adamič Š; Pirc B; Primic-Žakelj M; Stare J
    Breast cancer in reference to oral contraceptive use
    1985 ►

   1 101 201 301 401 501 601 701 801  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics